Protagonist Therapeutics Inc (PTGX)
Gross profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Gross profit | US$ in thousands | 26,646 | -5,035 | 252 | -19,732 | -15,862 |
| Revenue | US$ in thousands | 60,137 | 26,704 | 27,448 | 27,534 | 118 |
| Gross profit margin | 44.31% | -18.85% | 0.92% | -71.66% | -13,442.37% |
December 31, 2023 calculation
Gross profit margin = Gross profit ÷ Revenue
= $26,646K ÷ $60,137K
= 44.31%
The gross profit margin of Protagonist Therapeutics Inc has been volatile over the past five years, ranging from -13,442.37% in 2019 to 44.31% in 2023. A positive gross profit margin indicates that the company is generating profit from its core operations after accounting for the cost of goods sold. However, negative gross profit margins, such as those seen in 2020 and 2019, suggest that the company may be selling its products at a loss or facing challenges in managing production costs efficiently. It is crucial for Protagonist Therapeutics Inc to analyze the factors contributing to these fluctuations in order to sustainably improve its profitability in the future.
Peer comparison
Dec 31, 2023